JP2023518905A5 - - Google Patents
Info
- Publication number
- JP2023518905A5 JP2023518905A5 JP2022558519A JP2022558519A JP2023518905A5 JP 2023518905 A5 JP2023518905 A5 JP 2023518905A5 JP 2022558519 A JP2022558519 A JP 2022558519A JP 2022558519 A JP2022558519 A JP 2022558519A JP 2023518905 A5 JP2023518905 A5 JP 2023518905A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- kma
- kappa light
- composition
- chains
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2020900948 | 2020-03-27 | ||
| AU2020900948A AU2020900948A0 (en) | 2020-03-27 | Composition and method | |
| US202163200752P | 2021-03-25 | 2021-03-25 | |
| US63/200,752 | 2021-03-25 | ||
| PCT/IB2021/000171 WO2021191684A1 (en) | 2020-03-27 | 2021-03-26 | Composition and method |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023518905A JP2023518905A (ja) | 2023-05-08 |
| JP2023518905A5 true JP2023518905A5 (https=) | 2024-04-04 |
| JP7817945B2 JP7817945B2 (ja) | 2026-02-19 |
Family
ID=77890984
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022558519A Active JP7817945B2 (ja) | 2020-03-27 | 2021-03-26 | 組成物および方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US20240262928A1 (https=) |
| EP (1) | EP4126900A4 (https=) |
| JP (1) | JP7817945B2 (https=) |
| KR (1) | KR20230004543A (https=) |
| CN (1) | CN115551877A (https=) |
| AU (1) | AU2021244846A1 (https=) |
| BR (1) | BR112022019076A2 (https=) |
| CA (1) | CA3176109A1 (https=) |
| WO (1) | WO2021191684A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025213238A1 (en) * | 2024-04-12 | 2025-10-16 | HaemaLogiX Ltd | Anti-kma antibody formulations |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPR617901A0 (en) * | 2001-07-06 | 2001-08-02 | Pacmab Pty Ltd | Method for treating multiple myeloma |
| US20120114555A1 (en) * | 2009-04-07 | 2012-05-10 | Immune System Therapeutics Ltd | Method for treating immune disorders |
| ES2982297T3 (es) * | 2009-12-18 | 2024-10-15 | Novartis Ag | Método de cromatografía de afinidad |
| WO2016031932A1 (ja) * | 2014-08-27 | 2016-03-03 | 田辺三菱製薬株式会社 | アルカリ洗浄によるＦｃ領域を有するタンパク質の製造方法 |
| WO2016149088A1 (en) * | 2015-03-13 | 2016-09-22 | Bristol-Myers Squibb Company | Use of alkaline washes during chromatography to remove impurities |
| BR112017022838A2 (en) * | 2015-04-23 | 2018-07-17 | Haemalogix Pty. Ltd | kappa myeloma antigen chimeric antigen receptors and their uses |
| EP3492493A4 (en) * | 2016-07-28 | 2020-03-18 | Kaneka Corporation | METHOD FOR PRODUCING AN ANTIBODY FRAGMENT |
| EP3774882A1 (en) * | 2018-03-29 | 2021-02-17 | Bristol-Myers Squibb Company | Methods of purifying monomeric monoclonal antibodies |
-
2021
- 2021-03-26 WO PCT/IB2021/000171 patent/WO2021191684A1/en not_active Ceased
- 2021-03-26 US US17/907,471 patent/US20240262928A1/en not_active Abandoned
- 2021-03-26 CA CA3176109A patent/CA3176109A1/en active Pending
- 2021-03-26 BR BR112022019076A patent/BR112022019076A2/pt unknown
- 2021-03-26 EP EP21774251.9A patent/EP4126900A4/en active Pending
- 2021-03-26 JP JP2022558519A patent/JP7817945B2/ja active Active
- 2021-03-26 AU AU2021244846A patent/AU2021244846A1/en active Pending
- 2021-03-26 CN CN202180023593.1A patent/CN115551877A/zh active Pending
- 2021-03-26 KR KR1020227037511A patent/KR20230004543A/ko active Pending
-
2024
- 2024-03-18 US US18/607,753 patent/US20240262925A1/en not_active Abandoned
-
2025
- 2025-10-15 US US19/358,931 patent/US20260035474A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6856610B2 (ja) | ヘテロ二量体免疫グロブリンの精製 | |
| JP7187436B2 (ja) | アフィニティークロマトグラフィー洗浄バッファー | |
| JP5567691B2 (ja) | Ｆｃ含有タンパク質を精製するためのクロマトグラフィー法 | |
| JP2024510098A5 (https=) | ||
| JP2018508188A5 (https=) | ||
| CA3158206A1 (en) | Modified immunoglobulins for targeting amyloid deposits cross-reference to related applications | |
| JPH0566397B2 (https=) | ||
| JP2025067915A5 (https=) | ||
| RU2019109975A (ru) | Способы очистки антител | |
| JP2023509390A5 (https=) | ||
| JP2021530244A5 (https=) | ||
| CN114269790B (zh) | 抗FXI/FXIa抗体、其抗原结合片段及医药用途 | |
| JP2023520969A5 (https=) | ||
| JP2022515258A5 (https=) | ||
| JP2022536659A5 (https=) | ||
| JP2023545183A5 (https=) | ||
| JP2024516098A5 (https=) | ||
| CN111163804A (zh) | 使用阳离子交换色谱法分离三轻链抗体 | |
| JP2023506834A5 (https=) | ||
| JP2005535562A5 (https=) | ||
| CN1311691A (zh) | 抗凝剂和人源化抗冯·维勒布兰德氏因子的单克隆抗体 | |
| CN112851813A (zh) | 一种抗pd-1抗体的纯化方法 | |
| JP2025505650A5 (https=) | ||
| CN114341184A (zh) | 抗FcRn抗体、其抗原结合片段及其医药用途 | |
| CA3141640A1 (en) | Anti-gal9 immune-inhibiting binding molecules |